205 results on '"De Souza, Cármino A."'
Search Results
2. ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
3. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
4. Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma
5. Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
6. Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma
7. Association of single nucleotide variants in VEGFA and KDR with the risk and angiogenic features of diffuse large B-cell lymphoma
8. Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
9. Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness
10. Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial
11. Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies
12. Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience
13. Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib
14. Impairment of thrombin generation in the early phases of the host response of sepsis
15. Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase
16. Quantifying loss of CD34+ cells collected by apheresis after processing for freezing and post-thaw
17. Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome
18. The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest
19. Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma
20. Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
21. Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America
22. External Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Strong Calibration in the Brazilian Prospective Hodgkin Lymphoma Registry
23. Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free Remission
24. Predictive Value of BCR::ABL1 Transcripts Kinetics in the Molecular Relapse of Chronic Myeloid Leukemia Patients after Tyrosine Kinase Inhibitors Discontinuation: Results from the DES-CML Study
25. Tyrosine Kinase Inhibitor Withdrawal Syndrome in Chronic Myeloid Leukemia Patients Participants of Two Discontinuation Clinical Trials
26. Polymorphisms of methylenetetrahydrofolate reductase ( MTHFR), methionine synthase ( MTR), methionine synthase reductase ( MTRR), and thymidylate synthase ( TYMS) in multiple myeloma risk
27. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
28. Skin and oral lesions associated to imatinib mesylate therapy
29. Angiogenesis’ related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients
30. AUTOLOGOUS HEMATOPOIETC CELL TRANSPLANTATION (HCT) FOR HODGKIN LYMPHOMA, REAL WORLD EXPERIENCE OF A SINGLE CENTER EXPERIENCE
31. THE OUTCOME OF PERIPHERAL T-CELL LYMPHOMA PATIENTS FAILING FIRST-LINE THERAPY, FROM PROSPECTIVE COHORT OF T-CELL BRAZIL PROJECT
32. Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
33. CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients – A Real-World Study
34. POSTER: CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients – A Real-World Study
35. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
36. High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysis
37. Chronic GVHD: predictive factor for rhinosinusitis in bone marrow transplantation
38. An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course
39. Computed tomography–based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma
40. Perforin and granzyme B involvement in oral lesions of lichen planus and chronic GVHD
41. Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population
42. Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients
43. TNF, IFNG, IL6, IL10 and TGFB1 gene polymorphisms in South and Southeast Brazil
44. Effects of high platelet concentration in collecting and freezing dry platelets concentrates
45. Update on chronic myeloid leukemia
46. AN UPDATED OF PIONEER PROJECT TO COLLECT DATA OF T-CELL NHL PATIENTS AMONG FIVE REGIONS OF BRAZIL. T-CELL BRAZIL PROJECT
47. HOW I TREAT DOUBLE-HIT LYMPHMOMA AND HGBL, NOS
48. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation
49. The expression of PRAME in chronic lymphoproliferative disorders
50. Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.